Anderson, John T.
Bonagura, Vincent R.
Cowan, Juthaporn
Hsu, Connie
Mustafa, S. Shahzad
Patel, Niraj C.
Routes, John M.
Sriaroon, Panida
Vinh, Donald C.
Hofmann, Jutta H.
Praus, Michaela
Rojavin, Mikhail A.
Funding for this research was provided by:
CSL Behring
Article History
Received: 15 June 2020
Accepted: 4 November 2020
First Online: 6 January 2021
Compliance with Ethical Standards
:
: JTA has served as a speaker, consultant, and clinical research principal site investigator for CSL Behring and Takeda. VRB has served as a speaker for CSL Behring and Takeda. JC has received research funding from CSL Behring and Octapharma and is a clinical trial site investigator for Takeda. CH has nothing to disclose. SSM has served as a speaker for CSL Behring, Genentech, Teva, AstraZeneca, and Regeneron and received research funding from CSL Behring, Shire, and Regeneron. NCP has served as a speaker for CSL Behring and Takeda, received research funding from CSL Behring and Takeda, and has served as an advisory board member for Horizon Therapeutics. JMR has served as a principal site investigator for CSL Behring and an independent contractor for Takeda. PS received a publication research grant from CSL Behring. DCV has received research funding from the Fonds de la recherche en santé du Quebec, Canadian Institutes of Health Research, the US Department of Defense, the Jeffrey Modell Foundation, La Fondation du Grand Défi Pierre Lavoie, and CSL Behring; has served as a speaker for CSL Behring and Avir Pharma; and has received clinical trial funding from CSL Behring and Cidara Therapeutics. JHH, MP, and MAR are employees of CSL Behring and own CSL Behring shares.
: This study was carried out in accordance with the International Council for Harmonisation (ICH) Good Clinical Practice (GCP) guidelines and in accordance with the 1964 Declaration of Helsinki and its later amendments. The clinical study protocol and all amendments were approved by the Independent Ethics Committees or the Institutional Review Boards of the participating centers.
: Informed consent was obtained from all patients or their relatives or legally accepted representatives.